Cargando…
Dynamic quantitative detection of ABC transporter family promoter methylation by MS-HRM for predicting MDR in pancreatic cancer
The main focus of the present study was to evaluate whether ABC transporter family promoter methylation predicted multidrug resistance in gemcitabine-resistant cancer cell lines (BxPC-3/Gem and PANC-1/Gem). Using low concentrations of gemcitabine, the cell lines acquired drug resistance with differe...
Autores principales: | Yao, Lie, Gu, Jichun, Mao, Yishen, Zhang, Xinju, Wang, Xiaoyi, Jin, Chen, Fu, Deliang, Li, Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840752/ https://www.ncbi.nlm.nih.gov/pubmed/29552197 http://dx.doi.org/10.3892/ol.2018.8041 |
Ejemplares similares
-
Methylation levels assessment with Methylation-Sensitive High-Resolution Melting (MS-HRM)
por: Samsø Mathiasen, Sally, et al.
Publicado: (2022) -
Identification of new interaction partners of the human ABC transporter MDR3
por: Kluth, Marianne, et al.
Publicado: (2014) -
Methylation Profile of Small Breast Cancer Tumors Evaluated by Modified MS–HRM
por: Krasnyi, Aleksey M., et al.
Publicado: (2023) -
Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
por: Muñoz Velasco, Raúl, et al.
Publicado: (2022) -
Evaluation the interaction of ABC multidrug transporter MDR1 with thymoquinone: substrate or inhibitor?
por: Keyvani, Vahideh, et al.
Publicado: (2020)